Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
30/05/2025
HP Inc. reported a net revenue of $13.22 billion for the second fiscal quarter, slightly higher than analysts' expectations of $13.14 billion.
Latest
2 m ago
Brain-computer interface concept anomaly rose, innovative medical straight-line limit up.
3 m ago
Sino-Science Vanguard opened significantly lower in early trading, falling about 14% at one point, and currently down more than 10%. Earlier, Sino-Science Vanguard announced that it has been suspended from participating in military supplies procurement activities.
5 m ago
Shutai Shen continued to rise sharply in early trading, with a gain of over 14%; Shutai Shen announced that the company had noticed the high level of attention in the market to the information about the "Priority Review Variety Publicity" column on the website of the Drug Evaluation Center of the National Medical Products Administration about the application of the company's controlling subsidiary Jiangsu Beijetai Biological Technology Co., Ltd. for "Injection STSP-0601"; the drug is currently in the public notice period, with the deadline for public notice being June 3, 2025. There is still a lot of uncertainty about whether the drug will enter the priority review process after the public notice period expires.
6 m ago
In terms of concept, EDA experienced a majority callback, Huada Jiutian fell by nearly 6%, while Guangli Micro, Taichi Stock, and Galen Electronics all dropped by more than 3%.
7 m ago
Stock prices plunged after trading hours! Gap (GAP.US) warned that tariffs may eat away 300 million in profits.
See all latest